Drug-eluting coronary stent competition likely to increase in the US

  • What is your 1Q16 coronary stent mix?

a. MDT
b. BSX – Synergy
c. BSX – all non-Synergy
d. ABT

  • What WAS your 4Q15 coronary drug eluting stent mix?

a. MDT
b. BSX – Synergy
c. BSX – all non-Synergy
d. ABT

  • What price premium (in %) is the BSX Synergy stent selling for in 1Q16?
  • Where do you forecast your % usage of BSX Synergy to be in 2Q16? And by end of 2016?